Last reviewed · How we verify
NCT04039711
Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections
NA trial testing Vaginal self-sampling in Genital Infection in 1,028 participants. Completed in 6 April 2018.
6 April 2018
Quick facts
| Lead sponsor | Hôpital Européen Marseille |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,028 |
| Start date | 20 October 2015 |
| Primary completion | 6 April 2018 |
| Estimated completion | 6 April 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Vaginal self-sampling
Conditions studied
- Genital Infection — all drugs for Genital Infection →
- Asymptomatic Infections — all drugs for Asymptomatic Infections →
Sponsor
Hôpital Européen Marseille
Who can join
Adults 18 to 65, female only, with Genital Infection or Asymptomatic Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Screening for genital infection (GI), sexually transmitted infection (STI) and asymptomatic carriage of group B streptococcus (GBS) in pregnant women is a common reason for medical appointments. Conventional testing is performed by using vaginal and/or cervical classic sampling (VCS). Vaginal self-sampling (VSS) has progressively emerged as an alternative to VCS for STI agent screening. The use of vaginal self-sampling (VSS) could facilitate follow-ups and potentially help in the prevention of gynaecological disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04039711
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vaginal self-sampling
Trials testing the same drug.
- NCT04841408 — Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium · NA · completed
Other Hôpital Européen Marseille trials
Trials by the same sponsor.
- NCT07422077 — Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service · NA · recruiting
- NCT07491315 — Is Post-exertional Symptom Exacerbation Specific to Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome? · NA · recruiting
- NCT06623188 — Treatment of Episodic Migraine With AURICular Neuromodulation · NA · recruiting
- NCT06332573 — Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer · NA · recruiting
- NCT05249283 — Self and Body Perception in Otoneurological Disorders: Translation and Validation of Measurement Scales · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04039711 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital Européen Marseille
- Last refreshed: 2 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04039711.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing